Mackenzie Financial’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,678
| Closed | -$131K | – | 1746 |
|
|
2024
Q4 | $131K | Buy |
+3,678
| New | +$131K | ﹤0.01% | 1611 |
|
|
2024
Q2 | – | Sell |
-553
| Closed | -$61.9K | – | 1591 |
|
|
2024
Q1 | $61.9K | Buy |
+553
| New | +$61.9K | ﹤0.01% | 1466 |
|
|
2023
Q2 | – | Sell |
-2,753
| Closed | -$283K | – | 1588 |
|
|
2023
Q1 | $283K | Sell |
2,753
-195
| -7% | -$20K | ﹤0.01% | 1205 |
|
|
2022
Q4 | $432K | Buy |
+2,948
| New | +$432K | ﹤0.01% | 974 |
|
|
2020
Q2 | – | Sell |
-4,231
| Closed | -$617K | – | 1088 |
|
|
2020
Q1 | $617K | Buy |
+4,231
| New | +$617K | ﹤0.01% | 770 |
|